Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 3
Submit an article Journal homepage
409
Views
13
CrossRef citations to date
0
Altmetric
Letter to the Editor

CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia

Hongjie ShenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
,
Hongying ChaoDepartment of Hematology, Second Hospital of Changzhou, Changzhou, P. R. China
,
Zixuan DingJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
,
Yufeng FengJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
,
Jiannong CenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
,
Jinlan PanJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
,
Jun HeJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
,
Ming ZhouDepartment of Hematology, Second Hospital of Changzhou, Changzhou, P. R. China
,
Zixing ChenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. China
&
Suning ChenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, P. R. ChinaCorrespondence[email protected]
 show all
Pages 820-822 | Received 03 Mar 2014, Accepted 22 Jun 2014, Published online: 13 Aug 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Juliana Alvarez Argote & Constantin A. Dasanu. (2018) ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival. Current Medical Research and Opinion 34:5, pages 757-763.
Read now

Articles from other publishers (12)

Diletta Fontana, Ilaria Crespiatico, Valentina Crippa, Federica Malighetti, Matteo Villa, Fabrizio Angaroni, Luca De Sano, Andrea Aroldi, Marco Antoniotti, Giulio Caravagna, Rocco Piazza, Alex Graudenzi, Luca Mologni & Daniele Ramazzotti. (2023) Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. Nature Communications 14:1.
Crossref
Yan‑Bo Nie, Meng Sun, Colin He, Man‑Kai Ju, Fu‑Ling Zhou, San‑Yun Wu, Yi Zhou, Li Liu, Hui Shen, Ting‑Ting Huang, Pan Liu, Ying Xu, Liang Shao & Xue‑Lan Zuo. (2018) ASXL1 mutations in Chinese patients with essential thrombocythemia. Experimental and Therapeutic Medicine.
Crossref
L Falchi, H M Kantarjian & S Verstovsek. (2017) Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era. Leukemia 31:9, pages 1845-1854.
Crossref
Sarah Martin, Casey M. Wright & Linda M. Scott. (2017) Progenitor genotyping reveals a complex clonal architecture in a subset of CALR- mutated myeloproliferative neoplasms . British Journal of Haematology 177:1, pages 55-66.
Crossref
Yu-Qing Pei, Yue Wu, Fei Wang & Wei Cui. (2016) Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of Hematology 95:9, pages 1391-1398.
Crossref
Yonggoo Kim, Joonhong Park, Irene Jo, Gun Dong Lee, Jiyeon Kim, Ahlm Kwon, Hayoung Choi, Woori Jang, Hyojin Chae, Kyungja Han, Ki-Seong Eom, Byung-Sik Cho, Sung-Eun Lee, Jinyoung Yang, Seung-Hwan Shin, Hyunjung Kim, Yoon Ho Ko, Haeil Park, Jong Youl Jin, Seungok Lee, Dong Wook Jekarl, Seung-Ah Yahng & Myungshin Kim. (2016) Genetic–pathologic characterization of myeloproliferative neoplasms. Experimental & Molecular Medicine 48:7, pages e247-e247.
Crossref
Kolsoum Saeidi. (2016) Myeloproliferative neoplasms: Current molecular biology and genetics. Critical Reviews in Oncology/Hematology 98, pages 375-389.
Crossref
Hao Kong, Yancheng Liu, Sai Luo, Qiaoqiao Li & Qinglu Wang. (2016) Frequency of Calreticulin (CALR) Mutation and Its Clinical Prognostic Significance in Essential Thrombocythemia and Primary Myelofibrosis: A Meta-analysis. Internal Medicine 55:15, pages 1977-1984.
Crossref
Haixiu Guo, Xiuhua Chen, Ruiyuan Tian, Jianmei Chang, Jianlan Li, Yanhong Tan, Zhifang Xu, Fanggang Ren, Junxia Zhao, Jie Pan, Na Zhang, Xiaojuan Wang, Jianxia He, Wanfang Yang & Hongwei Wang. (2015) Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms. PLOS ONE 10:9, pages e0138250.
Crossref
Yining Yang, Xiaorui Wang, Chun Wang & Youwen Qin. (2014) A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia. International Journal of Hematology 101:2, pages 165-172.
Crossref
Bo Hyun Kim, Young-Uk Cho, Mi-Hyun Bae, Seongsoo Jang, Eul-Ju Seo, Hyun-Sook Chi, Yunsuk Choi, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Young-Mi Park, Jong-Keuk Lee & Chan-Jeoung Park. (2015) JAK2 V617F, MPL , and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis . Journal of Korean Medical Science 30:7, pages 882.
Crossref
Sang Hyuk ParkShine Young KimSun Min LeeJongyoun YiIn-Suk KimHyung Hoi KimChulhun Ludgerus ChangEun Yup LeeMoo-Kon SongHo-Jin ShinJoo Seop Chung. (2015) Incidence, Clinical Features, and Prognostic Impact of CALR Exon 9 Mutations in Essential Thrombocythemia and Primary Myelofibrosis: An Experience of a Single Tertiary Hospital in Korea . Annals of Laboratory Medicine 35:2, pages 233.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.